INCY vs NGNE · P/E 14, rev $5.14B vs $286.5M cap
Incyte Corporation (INCY) versus Neurogene Inc (NGNE) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. NGNE currently screens at market cap $286.5M.
Not investment advice. Open the INCY and NGNE stock pages for the full models.
Not investment advice.